First phase trial of India's COVID-19 vaccine Covaxin begins on 375 people: Report
New Delhi: India's Bharat Biotech International Limited, which claimed to have created the country's first potential indigenous coronavirus disease (Covid-19) vaccine, has said the first phase of testing it on 375 people has started, media reports said.
Hindustan, Hindustan Time’s sister publication, reported that Bharat Biotech has said that human trials of Covaxin started on July 15. The Hyderabad-based pharmaceutical company has jointly developed the vaccine with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Twelve hospitals in different parts of the country are carrying out this test, reports Hindustan Times.
The indigenous, inactivated vaccine has been developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad, India.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
